by Richard A. Hendricks | Sep 25, 2020 | Health News
The trial has been on hold in the United States for more than two weeks, and regulators face the task of trying to figure out if these illnesses were random and disconnected from the vaccine, or if they are related to the vaccine. AstraZeneca and its partner, the University of Oxford, have given various accounts […]
by Richard A. Hendricks | Sep 17, 2020 | Health News
The report details how the study volunteer, a previously healthy 37-year-old woman, “experienced confirmed transverse myelitis” after receiving her second dose of the vaccine, and was hospitalized on September 5. Four days later, AstraZeneca dismissed...
by Richard A. Hendricks | Sep 15, 2020 | Health News
“The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader of viral research at the National Institute for Neurological Disorders and Stroke, an NIH division. “Everyone’s hopes are on a...
by Richard A. Hendricks | Sep 14, 2020 | Health News
One such candidate is in development by the American pharmaceutical company Pfizer, which announced along with its German partner BioNTech on Saturday they proposed expanding Phase 3 clinical trials to include 44,000 participants and more diverse patient populations,...
by Richard A. Hendricks | Sep 12, 2020 | Health News
The university, which is developing the vaccine with AstraZeneca, did not say when the trial would resume. AstraZeneca said the trial will only resume in the United Kingdom, adding that it’s working with health authorities across the world to determine when...
